These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 36560664)

  • 21. Small molecule pan-dengue and West Nile virus NS3 protease inhibitors.
    Cregar-Hernandez L; Jiao GS; Johnson AT; Lehrer AT; Wong TA; Margosiak SA
    Antivir Chem Chemother; 2011 May; 21(5):209-17. PubMed ID: 21566267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploiting Dengue Virus Protease as a Therapeutic Target: Current Status, Challenges and Future Avenues.
    Mushtaq M; Naz S; Parang K; Ul-Haq Z
    Curr Med Chem; 2021; 28(37):7767-7802. PubMed ID: 34212826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of Multitarget Antivirals Acting on Both the Dengue Virus NS5-NS3 Interaction and the Host Src/Fyn Kinases.
    Vincetti P; Caporuscio F; Kaptein S; Gioiello A; Mancino V; Suzuki Y; Yamamoto N; Crespan E; Lossani A; Maga G; Rastelli G; Castagnolo D; Neyts J; Leyssen P; Costantino G; Radi M
    J Med Chem; 2015 Jun; 58(12):4964-75. PubMed ID: 26039671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of fused bicyclic derivatives of pyrrolidine and imidazolidinone as dengue virus-2 NS2B-NS3 protease inhibitors.
    Weng Z; Shao X; Graf D; Wang C; Klein CD; Wang J; Zhou GC
    Eur J Med Chem; 2017 Jan; 125():751-759. PubMed ID: 27721158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target.
    Lescar J; Luo D; Xu T; Sampath A; Lim SP; Canard B; Vasudevan SG
    Antiviral Res; 2008 Nov; 80(2):94-101. PubMed ID: 18674567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity.
    Takagi Y; Matsui K; Nobori H; Maeda H; Sato A; Kurosu T; Orba Y; Sawa H; Hattori K; Higashino K; Numata Y; Yoshida Y
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3586-3590. PubMed ID: 28539222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A quinoline compound inhibits the replication of dengue virus serotypes 1-4 in Vero cells.
    Beesetti H; Tyagi P; Medapi B; Krishna VS; Sriram D; Khanna N; Swaminathan S
    Antivir Ther; 2018; 23(5):385-394. PubMed ID: 29583121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Transcriptomics-Based Bioinformatics Approach for Identification and In Vitro Screening of FDA-Approved Drugs for Repurposing against Dengue Virus-2.
    Punekar M; Kasabe B; Patil P; Kakade MB; Parashar D; Alagarasu K; Cherian S
    Viruses; 2022 Sep; 14(10):. PubMed ID: 36298705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Narasin, a novel antiviral compound that blocks dengue virus protein expression.
    Low JS; Wu KX; Chen KC; Ng MM; Chu JJ
    Antivir Ther; 2011; 16(8):1203-18. PubMed ID: 22155902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel 2-phenyl-5-[(E)-2-(thiophen-2-yl)ethenyl]-1,3,4-oxadiazole and 3-phenyl-5-[(E)-2-(thiophen-2-yl)ethenyl]-1,2,4-oxadiazole derivatives as dengue virus inhibitors targeting NS5 polymerase.
    Benmansour F; Eydoux C; Querat G; de Lamballerie X; Canard B; Alvarez K; Guillemot JC; Barral K
    Eur J Med Chem; 2016 Feb; 109():146-56. PubMed ID: 26774922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and characterization of new potent inhibitors of dengue virus NS5 proteinase from Andrographis paniculata supercritical extracts on in animal cell culture and in silico approaches.
    Kaushik S; Dar L; Kaushik S; Yadav JP
    J Ethnopharmacol; 2021 Mar; 267():113541. PubMed ID: 33152438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a new dengue virus inhibitor that targets the viral NS4B protein and restricts genomic RNA replication.
    van Cleef KW; Overheul GJ; Thomassen MC; Kaptein SJ; Davidson AD; Jacobs M; Neyts J; van Kuppeveld FJ; van Rij RP
    Antiviral Res; 2013 Aug; 99(2):165-71. PubMed ID: 23735301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual targeting of dengue virus virions and NS1 protein with the heparan sulfate mimic PG545.
    Modhiran N; Gandhi NS; Wimmer N; Cheung S; Stacey K; Young PR; Ferro V; Watterson D
    Antiviral Res; 2019 Aug; 168():121-127. PubMed ID: 31085206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel dengue virus NS2B/NS3 protease inhibitors.
    Wu H; Bock S; Snitko M; Berger T; Weidner T; Holloway S; Kanitz M; Diederich WE; Steuber H; Walter C; Hofmann D; Weißbrich B; Spannaus R; Acosta EG; Bartenschlager R; Engels B; Schirmeister T; Bodem J
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1100-9. PubMed ID: 25487800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure activity relationship (SAR) and quantitative structure activity relationship (QSAR) studies showed plant flavonoids as potential inhibitors of dengue NS2B-NS3 protease.
    Sarwar MW; Riaz A; Dilshad SMR; Al-Qahtani A; Nawaz-Ul-Rehman MS; Mubin M
    BMC Struct Biol; 2018 Apr; 18(1):6. PubMed ID: 29673347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potent Allosteric Dengue Virus NS5 Polymerase Inhibitors: Mechanism of Action and Resistance Profiling.
    Lim SP; Noble CG; Seh CC; Soh TS; El Sahili A; Chan GK; Lescar J; Arora R; Benson T; Nilar S; Manjunatha U; Wan KF; Dong H; Xie X; Shi PY; Yokokawa F
    PLoS Pathog; 2016 Aug; 12(8):e1005737. PubMed ID: 27500641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cordycepin Inhibits Virus Replication in Dengue Virus-Infected Vero Cells.
    Panya A; Songprakhon P; Panwong S; Jantakee K; Kaewkod T; Tragoolpua Y; Sawasdee N; Lee VS; Nimmanpipug P; Yenchitsomanus PT
    Molecules; 2021 May; 26(11):. PubMed ID: 34071102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phytochemical Compound Screening to Identify Novel Small Molecules against Dengue Virus: A Docking and Dynamics Study.
    Shimu MSS; Mahmud S; Tallei TE; Sami SA; Adam AA; Acharjee UK; Paul GK; Emran TB; Zaman S; Uddin MS; Saleh MA; Alshehri S; Ghoneim MM; Alruwali M; Obaidullah AJ; Jui NR; Kim J; Kim B
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35163918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Betulinic acid exhibits antiviral effects against dengue virus infection.
    Loe MWC; Hao E; Chen M; Li C; Lee RCH; Zhu IXY; Teo ZY; Chin WX; Hou X; Deng J; Chu JJH
    Antiviral Res; 2020 Dec; 184():104954. PubMed ID: 33080251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication.
    Kouretova J; Hammamy MZ; Epp A; Hardes K; Kallis S; Zhang L; Hilgenfeld R; Bartenschlager R; Steinmetzer T
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):712-721. PubMed ID: 28385094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.